Topical application of substance P promotes wound healing in streptozotocin-induced diabetic rats

Cytokine

Volumn 73, Issue 1, 2015, Pages 144-155

  Kant, Vinay ^a   Kumar, Dinesh ^a   Kumar, Dhirendra ^a   Prasad, Raju ^a   Gopal, Anu ^a   Pathak, Nitya N ^a   Kumar, Pawan ^a   Tandan, Surender K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Diabetic rats; Epithelial layer; Microvessel density; Substance P; Wound healing

Indexed keywords

COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; NEUROMODULIN; POLOXAMER; SODIUM CHLORIDE; STREPTOZOCIN; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CD31 ANTIGEN; GLUCOSE BLOOD LEVEL; MESSENGER RNA; VASCULOTROPIN A;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GEL; GRANULATION TISSUE; HISTOPATHOLOGY; INFLAMMATORY CELL; MALE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; SKIN EPITHELIUM; SKIN FIBROBLAST; SKIN INJURY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WOUND CLOSURE; WOUND HEALING; ANGIOGENESIS; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; NERVE REGENERATION; PATHOLOGY; TOPICAL DRUG ADMINISTRATION; WISTAR RAT;

RATTUS;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS, CD31; AXONS; BLOOD GLUCOSE; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; GAP-43 PROTEIN; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE FIBERS; NERVE REGENERATION; NITRIC OXIDE SYNTHASE TYPE III; RATS, WISTAR; RNA, MESSENGER; STREPTOZOCIN; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84924092182     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.12.015     Document Type: Article

References (64)

1. Alba-Loureiro T.C., Hirabara S.M., Mendonca J.R., Curi R., Pithon-Curi T.C. Diabetes causes marked changes in function and metabolism of rat neutrophils. J Endocrinol 2006, 188:295-303.
2. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53:195-199.
3. Gallagher K.A., Liu Z.J., Xiao M., Chen H., Goldstein L.J., Buerk D.G., et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007, 117:1249-1259.
4. Kunt T., Forst T., Schmidt S., Pfutzner A., Schneider S., Harzer O., et al. Serum levels of substance P are decreased in patients with type 1 diabetes. Exp Clin Endocrinol Diabetes 2000, 108:164-167.
5. Muangman P., Muffley L.A., Anthony J.P., Spenny M.L., Underwood R.A., Olerud J.E., et al. Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen 2004, 12:44-52.
6. Dunnick C.A., Gibran N.S., Heimbach D.M. Substance P has a role in neurogenic mediation of human burn wound healing. J Burn Care Rehabil 1996, 17:390-396.
7. Pernow B. Substance P. Pharmacol Rev 1983, 35(2):85-141.
8. Vishwanath R., Mukherjee R. Substance P promotes lymphocyte endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. J Neuroimmunol 1996, 71(1-2):163-171.
9. Pradhan L., Nabzdyk C., Andersen N.D., LoGerfo F.W., Veves A. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med 2009, 11:e2.
10. Theoharides T.C., Zhang B., Kempuraj D., Tagen M., Vasiadi M., Angelidou A., et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA 2010, 107:4448-4453.
11. Kant V., Gopal A., Kumar D., Bag S., Kurade N.P., Kumar A., et al. Topically applied substance P enhanced healing of open excisionwoundin rats. Eur J Pharmacol 2013, 715:345-353.
12. Benrath J., Zimmerman M., Gillardon F. Substance P and nitric oxide mediate would healing of ultraviolet photodamaged rat skin: evidence for an effect of nitric oxide on keratinocyte proliferation. Neurosci Lett 1995, 200:17-20.
13. Burssens P., Steyaert A., Forsyth R., van Ovost E.J., Depaepe Y., Verdonk R. Exogenously administered substance P and neutral endopeptidase inhibitors stimulate fibroblast proliferation, angiogenesis and collagen organization during Achilles tendon healing. Foot Ankle Int 2005, 26(10):832-839.
14. Lindberger M., Daa Schroder H., Schultzberg M., Kristensson K., Persson A., Ostman J., et al. Nerve fibre studies in skin biopsies in peripheral neuropathies. J Neurol Sci 1989, 93:289-296.
15. Gibran N.S., Jang Y.C., Isik F.F., Greenhalgh D.G., Muffley L.A., Underwood R.A., et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002, 108:122-128.
16. Delgado A.V., McManus A.T., Chambers J.P. Exogenous administration of substance P enhances wound healing in a novel skin-injury model. Exp Biol Med 2005, 230:271-280.
17. Kant V., Gopal A., Kumar D., Gopalkrishnan A., Pathak N.N., Kurade N.P., et al. Topical pluronic F-127 gel application enhances cutaneous wound healing in rats. Acta Histochem 2014, 116:5-13.
18. Livak K.J., Schmitten T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta(CT)). Methods 2001, 25:402-408.
19. Greenhalgh D.G., Sprugel K.H., Murray M.J., Ross R. PDGF and FGF stimulate healing in the genetically diabetic mouse. Am J Pathol 1990, 136:1235-1246.
20. Dayan D., Hiss Y., Hirshberg A., Bubis J.J., Wolman M. Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers?. Histochemistry 1989, 93:27-29.
21. Jain M., Logerfo F.W., Guthrie P., Pradhan L. Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cells. J Vasc Surg 2011, 53:1654-1660.
22. Wetzler C., Kampfer H., Stallmeyer B., Pfeilschifter J., Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000, 115:245-253.
23. Roth D., Piekarek M., Paulsson M., Christ H., Krieg T., Davidson J.M., et al. Plasmin modulates VEGF-A mediated angiogenesis duringwound repair. Am J Pathol 2006, 168:670-684.
24. Riches D.W.H. Macrophage involvement in wound repair, remodeling and fibrosis. The molecular and cellular biology of wound repair 1996, 95-141. Plenum, New York, London. 2nd ed. R.A.F. Clark (Ed.).
25. Engelhardt E., Toksoy A., Goebeler M., Debus S., Brocker E.B., Gillitzer R. Chemokines IL-8, Groα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998, 153:1849-1860.
26. Daley J.M., Brancato S.K., Thomay A.A., Reichner J.S., Albina J.E. The phenotype of murine wound macrophages. J Leukoc Biol 2010, 87:59-67.
27. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010, 184:3964-3977.
28. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
29. Khanna S., Biswas S., Shang Y., Collard E., Azad A., Kauh C., et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 2010, 5(3):e9539. 10.1371/journal.pone.0009539.
30. Mirza R., Koh T.J. Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine 2011, 56:256-264.
31. Nwomeh B.C., Yager D.R., Cohen I.K. Physiology of the chronic wound. Clin Plast Surg 1998, 25(3):341-356.
32. Goren I., Muller E., Schiefelbein D., Christen U., Pfeilschifter J., Muhl H., et al. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 2007, 127:2259-2267.
33. Lai J.J., Lai K.P., Chuang K.H., Chang P., Yu I.C., Lin W.J., et al. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest 2009, 119:3739-3751.
34. Leal EC, Tellechea A, Kuchibhotla S, Auster ME, LoGerfo FW, Pradhan-Nabzdyk L, et al. SP regulates macrophage function in diabetic wound healing (Abstract). In: 50th EASD annual meeting. Vienna, Austria; 15th - 19th September 2014. http://www.easdvirtualmeeting.org/resources/19395.
35. Jiang M.H., Chung E., Chi G.F., Ahn W., Lim J.E., Hong H.S., et al. Substance P induces M2-type macrophages after spinal cord injury. NeuroReport 2012, 23(13):786-792.
36. Lundvig D.M., Immenschuh S., Wagener F.A. Hemeoxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?. Front Pharmacol 2012, 3:81.
37. Kook Y.A., Lee S.K., Son D.H., Kim Y., Kang K.H., Cho J.H., et al. Effects of substance P on osteoblastic differentiation and heme oxygenase-1 in human periodontal ligament cells. Cell Biol Int 2009, 33:424-428.
38. Moore K.W., Waal D.E., Malefyt R., Coffman R.L., O'garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
39. Mosser D.M., Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008, 226:205-218.
40. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., et al. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986, 83:4167-4171.
41. Jiang M.H., Chung E., Chi G.F., Ahn W., Lim J.E., Hong H.S., et al. Substance P induces M2-type macrophages after spinal cord injury. NeuroReport 2012, 23:786-792.
42. Johnson K.E., Wilgus T.A. Multiple roles for VEGF in non-melanoma skin cancer: angiogenesis and beyond. J Skin Cancer 2012, 6 pages, Article ID 483439.
43. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001, 280:C1358-C1366.
44. Fang S., Pentinmikko N., Ilmonen M., Salven P. Dual action of TGF-beta induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cells. Angiogenesis 2012, 15:511-519.
45. Rivard A., Silver M., Chen D., Kearney M., Magner M., Annex B., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999, 154:355-363.
46. Al-Mulla F., Leibovich S.J., Francis I.M., Bitar M.S. Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Mol BioSyst 2011, 7:3006-3020.
47. Martin A., Komada M.R., Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003, 23:117-145.
48. Grochot-Przeczek A., Lach R., Mis J., Skrzypek K., Gozdecka M., Sroczynska P., et al. Heme oxygenase-1 accelerates cutaneous wound healing in mice. PLoS ONE 2009, 4:e5803.
49. Lin H.H., Chen Y.H., Chang P.F., Lee Y.T., Yet S.F., Chau L.Y. Heme oxygenase-1 promotes neovascularization in ischemic heart by co-induction of VEGF and SDF-1. J Mol Cell Cardiol 2008, 45:44-55.
50. Yu J., deMuinck E.D., Zhuang Z., Drinane M., Kauser K., Rubanyi G.M., et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA 2005, 102:10999-11004.
51. Lee P.C., Salyapongse A.N., Bragdon G.A., Shears L.L., Watkins S.C., Edington H.D., et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol Heart Circ Physiol 1999, 277:H1600-H1608.
52. Luo J.D., Wang Y.Y., Fu W., Wu J., Chen A.F. Gene therapy of eNOS and MnSOD restores delayed wound healing in type 1 diabetic mice. Circulation 2004, 110(16):2484-2493.
53. Nalbone G., Alessi M.C., Juhan-Vague I. Systèmefibrinolytique, metalloproteases et pathologievasculaire. Medecine/Sciences 2001, 17:170-176.
54. Wall S.J., Bevan D., Thomas D.W., Harding K.G., Edwards D.R., Murphy G. Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Invest Dermatol 2002, 119(1):91-98.
55. McLennan S.V., Death A.K., Fisher E.J., Williams P.F., Yue D.K., Turtle J.R. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol 1999, 45:123-135.
56. Bae S.H., Bae Y.C., Nam S.B., Choi S.J. A skin fixation method for decreasing the influence of wound contraction on wound healing in a rat model. Arch Plast Surg 2012, 39(5):457-462.
57. Lal B.K., Saito S., Pappas P.J., Padberg F.T., Cerveira J.J., Hobson R.W. Altered proliferative responses of dermal fibroblasts to TGF-betal may contribute to chronic venous stasis ulcer. J Vasc Surg 2003, 37:1285-1293.
58. Salomon G.D., Kasid A., Cromack D.T., Director E., Talbot T.L., Sank A., et al. The local effects of cachectin/tumor necrosis factor on wound healing. Ann Surg 1991, 214:175-180.
59. Goldberg M.T., Han Y.P., Yan C., Shaw M.C., Garner W.L. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol 2007, 127:2645-2655.
60. Ribeiro M.A., Albuquerque R.L., Ramalho L.M., Pinheiro A.L., Bonjardim L.R., Da Cunha S.S. Immunohistochemical assessment of myofibroblasts and lymphoid cells during wound healing in rats subjected to laser photobiomodulation at 660nm. Photomed Laser Surg 2009, 27:49-55.
61. Bisby M.A. Axonal transport of labeled protein and regeneration rate in nerves of streptozocin-diabetic rats. Exp Neurol 1980, 69:74-84.
62. 2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers. Clin Neurophysiol 2010, 121:1256-1266.
63. Verze L., Paraninfo A., Ramieri G., Viglietti-Panzica C., Panzica G.C. Immunocytochemical evidence of plasticity in the nervous structures of the rat lower lip. Cell Tissue Res 1999, 297:203-211.
64. Bursova S., Dubovy P., Vlckova-Moravcova E., Nemec M., Klusakova I., Belobradkova J., et al. Expression of growth-associated protein 43 in the skin nerve fibers of patients with type 2 diabetes mellitus. J Neurol Sci 2012, 315:60-63.